Reynders McVeigh Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-4,582	Closed	-$423K	–	206
2024 Q2	$423K	Hold	4,582	–	–	0.02%	146
2024 Q1	$438K	Sell	4,582 -870	-16%	-$73.1K	0.03%	144
2023 Q4	$416K	Buy	5,452 +625	+13%	+$43.5K	0.03%	143
2023 Q3	$334K	Sell	4,827 -374	-7%	-$30.1K	0.02%	158
2023 Q2	$491K	Sell	5,201 -165	-3%	-$14.3K	0.03%	138
2023 Q1	$444K	Buy	5,366 +275	+5%	+$21.6K	0.03%	143
2022 Q4	$380K	Sell	5,091 -77	-1%	-$5.93K	0.03%	160
2022 Q3	$427K	Buy	5,168 +1,055	+26%	+$102K	0.03%	150
2022 Q2	$391K	Hold	4,113	–	–	0.03%	165
2022 Q1	$484K	Hold	4,113	–	–	0.03%	158
2021 Q4	$533K	Sell	4,113 -1	-0%	-$117	0.03%	159
2021 Q3	$466K	Hold	4,114	–	–	0.03%	159
2021 Q2	$426K	Sell	4,114 -87	-2%	-$8.2K	0.03%	168
2021 Q1	$351K	Buy	4,201 +3	+0.1%	+$254	0.02%	183
2020 Q4	$383K	Buy	4,198 +4	+0.1%	+$332	0.03%	170
2020 Q3	$335K	Sell	4,194 -84	-2%	-$6.55K	0.03%	173
2020 Q2	$296K	Buy	4,278 +183	+4%	+$13K	0.03%	177
2020 Q1	$257K	Buy	4,095 +24	+0.6%	+$1.73K	0.03%	166
2019 Q4	$317K	Buy	+4,071	New	+$318K	0.03%	188